Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Establishing a Center for the Advancement of Substance Use…

U.S. National Institutes of Health·United States of America

Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)

Closes 9/30/2026$2M – $4MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institute on Drug Abuse (NIDA) seeks to establish a Center that educates and supports researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics. The Center will also help advance the best concepts through initial experiments via technical and financial support. Key aspects of the job include: • Developing plans for a product development curriculum to be taught to SUD researchers • Outlining outreach and networking initiatives to engage the research community and recruit researchers' concepts for development within the Center • Describing the infrastructure support that may be provided for initial experiments • Leading the outreach and networking efforts for the Center • Developing a comprehensive teaching curriculum in SUD drug discovery and development for the Center • Leading and assisting in preclinical studies including determining experimental approaches, designing protocols, conducting experiments, and analyzing and interpreting research data

Attached files

Contact

Tam Nguyen(Chief Grants Management Officer; Scientific/Research Contact; Peer Review Contact; Application Submission Contact; Financial/Grants Management Contact)

[email protected]; [email protected]; [email protected]; [email protected]

(301) 451-1203

Key dates

Opened
8/28/2025
Closes
9/30/2026
Projected award
12/1/2026
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-DA-27-015

Budget estimate

$2,000,000 – $4,000,000

The estimated budget for this opportunity is $3,000,000. This amount is specified in the document as the estimated funding for the project. The actual budget may vary based on various factors, including the specific requirements of the project and the qualifications of the applicants. The factors that may influence the likely payment range include the scope of work, the complexity of the project, and the number of awards.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 75%

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Closes 8/21/2028Opened 5/13/2025

U.S. National Institutes of Health·United States of America

74% match

Specialized Alcohol Research Centers (P50 Clinical trial Optional)

Closes 1/27/2027Opened 1/30/2026

U.S. National Institutes of Health·United States of America

73% match

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. National Institutes of Health·United States of America

73% match

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

Closes 11/13/2026Opened 1/3/2024

U.S. National Institutes of Health·United States of America

73% match

Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 5/28/2027Opened 12/22/2025

U.S. National Institutes of Health·United States of America

72% match

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)

Closes 10/25/2027Opened 1/15/2025

U.S. National Institutes of Health·United States of America

72% match

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

Closes 10/25/2027Opened 1/15/2025

U.S. National Institutes of Health·United States of America

72% match

HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

Closes 2/9/2029Opened 6/4/2026

U.S. National Institutes of Health·United States of America

72% match

Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)

Closes 9/9/2027Opened 9/20/2024

Arkansas Department of Finance and Administration·Arkansas

72% match

Residential Substance Abuse Treatment For State Prisoners Program (RSAT)

Rolling / TBD closeOpened 12/12/2024

U.S. Food and Drug Administration·United States of America

71% match

Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

Rolling / TBD closeOpened 8/14/2024

Maryland Department of Public Safety and Correctional Services·Maryland

71% match

Substance Use Disorder Treatment Services - DOC Facilities Statewide

Closes 11/12/2026Opened 10/2/2026

U.S. National Institutes of Health·United States of America

71% match

Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

Closes 7/16/2029Opened 1/26/2026

U.S. Food and Drug Administration·United States of America

71% match

Center for Research on Complex Generics (U18) Clinical Trials Optional

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

71% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026

U.S. National Institutes of Health·United States of America

71% match

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

Closes 3/6/2027Opened 8/2/2024

U.S. National Institutes of Health·United States of America

71% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. National Institutes of Health·United States of America

71% match

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Closes 3/16/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

71% match

Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)

Closes 5/26/2028Opened 12/10/2025

U.S. National Institutes of Health·United States of America

71% match

Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed)

Closes 4/9/2027Opened 3/12/2025

U.S. National Institutes of Health·United States of America

71% match

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

71% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

71% match

Network of the National Library of Medicine Training Center (U24 Clinical Trial Not Allowed)

Closes 12/14/2026Opened 2/11/2026

U.S. Food and Drug Administration·United States of America

71% match

Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

71% match

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024